(Q80952560)

English

Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation

scientific article published on 01 November 2004

Statements

Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit